X
API Suppliers
US DMFs Filed
CEP/COS Certifications
JDMFs Filed
0
Other Certificates
Other Suppliers
USA (Orange Book)
Europe
Canada
Australia
South Africa
Uploaded Dossiers
U.S. Medicaid
Annual Reports
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=215124
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=211475
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=210169
https://endpts.com/fdas-antimicrobial-adcomm-unanimously-backs-takedas-drug-for-post-transplant-cytomegalovirus/
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=205151
https://www.prnewswire.com/news-releases/viracta-therapeutics-announces-notice-of-allowance-for-us-patent-application-covering-its-combination-product-candidate-for-the-treatment-of-viral-or-virally-induced-conditions-301091196.html
https://www.fiercebiotech.com/research/five-fda-approved-antivirals-could-target-covid-19-study
https://www.prnewswire.com/news-releases/viracta-therapeutics-announces-orphan-drug-designation-granted-for-the-treatment-of-t-cell-lymphoma-301083191.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=213306
https://www.moneycontrol.com/news/business/granules-india-arm-gets-usfda-nod-for-valganciclovir-hydrochloride-oral-solution-4907721.html
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212890
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=212234
https://www.business-standard.com/article/pti-stories/sun-pharma-gets-partial-relief-from-us-court-in-litigation-involving-three-generic-drugs-119120200818_1.html
https://www.fiercebiotech.com/biotech/takeda-s-cmv-med-outshines-roche-s-valcyte-phase-2
https://www.fiercepharma.com/pharma-asia/foreign-drugmakers-under-threat-as-china-rolls-out-drug-list-to-boost-generic
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=209672
https://www.pharmacompass.com/pdf/news/enforcement-report-week-of-march-21-2018-1521610042.pdf
https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=206876
https://www.pharmacompass.com/pdf/news/actavis-receives-fda-nod-for-valganciclovir-to-treat-cmv-infections-1469261978.pdf
https://www.pharmacompass.com/pdf/news/aurobindo-pharmas-generic-valganciclovir-hydrochloride-approved-in-us-for-cytomegalovirus-retinitis-1460028793.pdf
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/aurobindo-pharma-gets-final-usfda-nod-for-anti-viral-drug/articleshow/51645136.cms
https://www.pharmacompass.com/pdf/news/hetero-labs-generic-valganciclovir-hydrochloride-approved-in-us-to-treat-cytomegalovirus-infections-1459595784.pdf
http://www.forbes.com/sites/davidkroll/2015/12/31/the-drug-that-saved-josh-hardy-cost-chimerix-80-of-its-value-was-that-too-pessimistic/?ss=pharma-healthcare
http://health.economictimes.indiatimes.com/news/pharma/india-rejects-swiss-drug-maker-roche-patent-claims-on-valcyte-again/48195901
http://economictimes.indiatimes.com/industry/healthcare/biotech/pharmaceuticals/us-lawsuit-puts-generic-drug-imports-from-india-under-scanner/articleshow/47305780.cms
http://www.fiercepharmaasia.com/story/japan-mhlw-panel-names-11-unapprovedoff-label-drugs-fast-track-reviews/2015-04-27
http://www.reuters.com/article/2015/02/28/ranbaxy-lab-usa-idUSL4N0W205520150228
Market Place
Share 
